Buenos Aires, March 11 (NA) – Daniel Díaz, Head of Systems at Droguería Suizo Argentina, must appear for a hearing requested by Federal Prosecutor Carlos Rívolo due to his refusal to unlock the IT passwords of the company's executives. This is part of an investigation into irregularities at the National Agency for Disability (ANDIS). According to the prosecutor's filing, Díaz may have committed “obstruction of justice” as the probe investigates alleged overcharges by Suizo Argentina and other firms to ANDIS. In this context, the hearing aims to determine if there was an attempt to hinder the judicial investigation by blocking access to internal corporate communications, a measure that could be crucial to reconstructing the decisions and links between the company's executives and the contracts under investigation. In this case, the former director of ANDIS, Diego Spagnuolo, and 18 others, including Daniel Garbellini, Miguel Ángel Calvet, and Pablo Atchabahian, have been processed. The Justice investigation uncovered a corruption network involving the sale of supplies required by ANDIS for its beneficiaries, but with significant overprices agreed upon with the agency's authorities. Díaz, as learned by the Argentine News Agency, must explain why he refused to unlock the executives' passwords, to which he had access, which prevented the Justice from accessing the corporate emails required for the investigation. The refusal by the head of the IT area blocked judicial access to the corporate emails of the company's executives, considered a key piece of evidence in the investigation. The file seeks to determine if there were maneuvers to obstruct access to information that could be crucial to the progress of the case. The events involving Díaz occurred on August 29, 2025, during a raid on the company located at Monroe Avenue 801 in the city of Buenos Aires. The raid aimed to access the corporate and institutional emails of the pharmacy and to perform a 'mirror copy' of the files of about ten of the firm's executives to gather digital evidence on the case under investigation. The case is part of a broader investigation analyzing the link between Droguería Suizo Argentina and contracts made by ANDIS. The company belongs to the Kovalivker family, a business group that has controlled the firm for decades and is currently under judicial scrutiny for its involvement in operations linked to the public health system. Within this network, Jonathan Simón Kovalivker appears, one of the company's main shareholders along with his father Eduardo and his brothers, who would have held a strategic position in the relationship between the pharmacy and the state agency. The ANDIS case began in 2025 after the release of recordings attributed to then-head of the agency, Diego Spagnuolo, which mentioned alleged irregularities in the contracting of medicines and possible undue payments linked to supplier companies. Based on these revelations, the Justice opened several lines of investigation involving officials and businessmen from the sector.
